Paper Details Design of ADAPTABLE, First Pragmatic Trial to Use PCORnet®
Preventing Alzheimer’s Disease? Taking the First Step Through the TOMMORROW Trial
The study sought to simultaneously test a method for identifying individuals at high risk for Alzheimer’s disease while testing the efficacy of a potential treatment aimed at targets affecting cell
Patient-Reported Health Data in Pragmatic Trials: Helpful, But Not Without Limitations
Experts on data, including three DCRI faculty, recently published a report on using patient-reported health data in pragmatic trials that stemmed from an NIH Collaboratory roundtable.
12-month SECURE-PCI Results add Context to Original Findings
Patients with acute coronary syndrome undergoing PCI had a benefit 30 days after being treated with loading dose atorvastatin, but this benefit did not extend to the 12-month results.
New DCRI Registry Could Provide Path for Pediatric Migraine Drug Development
A recently published paper details the development and design of the FDA-funded Pediatric Migraine Registry, which has enrolled around 200 patients between the ages of 4 and 17.
Interventional Cardiologists Must Stay Up-to-date on Training to Avoid ‘Proficiency Divide’
The DCRI’s Sunil Rao, MD, writes that to deliver high quality care, interventional cardiologists must constantly evaluate their practice and learn new techniques and skills.
DCRI and Digital Solutions: A New World of Evidence Generation
From thought leadership on a national stage to driving adoption for digital health technologies, the DCRI is leading the way in the digital therapeutic space.
Special Considerations for Resuscitation of Older Patients
An editorial written by DCRI faculty discusses resuscitation, which may not always be the best option for older adults because of poor survival rates.
Resuscitation after out-of-hospital
UPDATE: DCRI Researchers Discuss Recruitment Challenges for Coronavirus Trials
System-Wide Change Needed to Conduct More Randomized Clinical Trials at Lower Cost
A focus on building a nationwide system of real-world data could provide the opportunity for more randomized clinical trials to generate needed evidence to inform health care decisions.